Pfizer Inc (PFE)

40.280
+0.160(+0.40%)
  • Volume:
    23,723
  • Bid/Ask:
    40.280/40.420
  • Day's Range:
    40.100 - 40.460

PFE Overview

Prev. Close
40.12
Day's Range
40.1-40.46
Revenue
76.04B
Open
40.46
52 wk Range
38.7-53.4
EPS
5.31
Volume
23,723
Market Cap
228.36B
Dividend (Yield)
1.64
(3.63%)
Average Volume (3m)
20,434
P/E Ratio
8.24
Beta
0.651
1-Year Change
-14.87%
Shares Outstanding
5,613,314,537
Next Earnings Date
01 May 2023
What is your sentiment on Pfizer?
or
Vote to see community's results!

Pfizer Inc News

Pfizer Inc Analysis

Pfizer Inc Company Profile

Pfizer Inc Company Profile

Employees
79000
  • Type:Equity
  • Market:Germany
  • ISIN:US7170811035
  • WKN:852009

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global contract development and manufacturing organization and supplier of specialty active pharmaceutical ingredients. Its Vaccines include Comirnaty/BNT162b2, the Prevnar family, Nimenrix and others. Its Oncology products include Ibrance, Xtandi, Inlyta, Sutent, Retacrit, Lorbrena and Braftovi. Its Internal Medicine products include Eliquis and the Premarin family. Its Inflammation & Immunology products include Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis and Cibinqo. It also offers Rimegepant and Zavegepant.

Read More

Analyst Price Target

Average54.300 (+22.962% Upside)
High75.000
Low44.000
Price44.160
No. of Analysts20
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyNeutralStrong SellNeutral
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Sell
SummaryStrong BuyStrong BuyNeutralStrong SellSell
  • Project Veritas...
    0
    • Still aiming for sub 40
      1
      • Great long term er at this price
        1
        • please never effective.inbox me for fast rising stocks
          1
          • Adverse Effects Rife
            0
            • No logic for drop. This is a 60 Euro stock value
              0
              • It will drop like a stone, when the FDA release the data.
                0
            • time to jump ship. New variants are weaker, hospitalisations are down, no longer a need for vaccine or meds. vaccine centres in the UK are now practically empty. It was a good two year ride, but time to bail.
              4
              • Strong buyPresident Biden has doubled commitment of the Pfizer pill treatment to at least 20 million courses as the Covid omicron variant rages.
                0
                • Why TF is this not rising ?
                  0
                  • The Covid Detector device has been added to the Register of rapid tests for the detection of SARS-CoV-2 virus in Austria. This instant contactless detector from ML System
                    0